Cofactor Genomics - About the company
Cofactor Genomics is a series A company based in San Francisco (United States), founded in 2009 by Dave Messina. It operates as a Developer of diagnostic assays using RNA sequencing. Cofactor Genomics has raised $26.2M in funding from investors like Y Combinator, Menlo Ventures and 7percent Ventures. The company has 15 active competitors, including 6 funded and 1 that has exited. Its top competitors include companies like Veracyte, HAYA Therapeutics and Alida Biosciences.
Company Details
Developer of diagnostic assays using RNA sequencing. The company's product includes ImmunoPrism is an RNA sequencing-based assay that uses predictive immune modeling to generate multidimensional biomarkers. It combines machine learning and RNA-sequencing to build gene expression models for immune cells. The company's models for key immune cells include Immune Health Expression Models, Immune Escape Genes, and Co-inhibitory molecules. The company's sequencing products include mRNAble, Total RNAble, picoRNA, FFPExact, miRNAble, RNAccess, RNAmplify, and RNAdvantage.
- Website
- cofactorgenomics.com
- Social
- Email ID
- *****@cofactorgenomics.com
- Phone Number
- +1 **********
- Registered Address
- St. Louis, Missouri
Key Metrics
Founded Year
2009
Location
San Francisco, United States
Stage
Series A
Total Funding
$26.2M in 7 rounds
Latest Funding Round
Investors
Ranked
3rd among 15 active competitors
Employee Count
12 as on Jul 31, 2026
Investment & Acquisitions
Legal entities associated with Cofactor Genomics
Cofactor Genomics is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Cofactor Genomics, Inc. CIN: 474418741 , United States, Active | Jun 11, 2015 | - | 9 (As on Dec 31, 2021) | - |
Sign up to download Cofactor Genomics' company profile
Cofactor Genomics's funding and investors
Cofactor Genomics has raised a total funding of $26.2M over 7 rounds. Its first funding round was on Sep 01, 2014. Its latest funding round was a Series A round on Dec 15, 2025 for $*****. 2 investors participated in its latest round. Cofactor Genomics has 20 institutional investors.
Here is the list of recent funding rounds of Cofactor Genomics:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 15, 2025 | 6455253 | Series A | 8681466 | 4556855 | 2178629 | 8899380 |
Aug 02, 2023 | 5739621 | Series A | 7930954 | 2305674 | 5838457 | 8550460 |
Dec 16, 2021 | 9048827 | Series A | 2978376 | 1830121 | 4934641 | 1401676 |
Access funding benchmarks and valuations. Sign up today!View details of Cofactor Genomics's funding rounds and investors
Cofactor Genomics' founders and board of directors
Founder? Claim ProfileThe founders of Cofactor Genomics is Dave Messina.
Here are the details of Cofactor Genomics' key team members:
- Dave Messina: Former Co-Founder of Cofactor Genomics. They are also an angel investor in 1 startup.Contact Info: 1 email address
Cofactor Genomics' Board of Directors
Cofactor Genomics's board has 8 active members. William Hagstrom, David Messina, Mark Siegel, Armen Vidian, John Kuelper, Jarret Glasscock, Matthew A. Ocko and Jarret Glassock are independent board members.Here is the list of Cofactor Genomics' board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Independent board member | - | Current | 4y 6m | |
sdhrbmn | Independent board member | - | Current | 4y 9m |
oeybcst | Independent board member | - | Current | 7y 1m |
mpu{ibg | Independent board member | - | Current | 3y 4m |
nkpbjge | Independent board member | - | Current | 6y 6m |
zlbugcv | Independent board member | - | Current | 1y 9m |
stcdarj | Independent board member | - | Current | 5y 2m |
dfz{xhz | Independent board member | - | Current | 3y 7m |
View details of Cofactor Genomics's Founder profiles and Board Members
Cofactor Genomics' employee count trend
Cofactor Genomics has 12 employees as of Jul 26. Here is Cofactor Genomics's employee count trend over the years:
Uncover Cofactor Genomics' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Cofactor Genomics's Competitors and alternates
Top competitors of Cofactor Genomics include Veracyte, HAYA Therapeutics and Alida Biosciences. Here is the list of Top 10 competitors of Cofactor Genomics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Veracyte 2008, San Francisco (United States), Public | Developer of genomics-based diagnostics for cancer | $67.9M | 61/100 | |
2nd |  HAYA Therapeutics 2017, Lausanne (Switzerland), Series A | Developer of RNA-based therapies for treating heart diseases | $90M | 58/100 | |
3rd | Cofactor Genomics 2009, San Francisco (United States), Series A | Developer of diagnostic assays using RNA sequencing | $26.2M | 55/100 | |
4th |  Alida Biosciences 2020, San Diego (United States), Series A | Provider of technology for RNA analysis to improve human health | $11.5M | 54/100 | |
5th | Novigenix 2014, Epalinges (Switzerland), Series B | Developer of technology for cancer precision medicine | $20M | 52/100 | |
6th |  Cajal Neuroscience 2020, Seattle (United States), Series A | Developer of drugs for neurodegenerative disease based on genetic screening, and multi-omics approach | $96M | 46/100 | |
7th | PeriRx 2008, Broomall (United States), Funding Raised | Developer of saliva-based risk stratification test for oral cancer | - | 33/100 | |
8th | Isoma Diagnostics 2017, Philadelphia (United States), Funding Raised | Molecular diagnostic tests for stratification of Glioblastoma | - | 29/100 | |
9th | Biomedica Immunoassays 1992, Vienna (Austria), Unfunded | Developer of ELISAs kits for detecting circulating microRNAs | - | - | 28/100 |
10th | Nova Satra 2014, Singapore (Singapore), Seed | Provider of non-invasive diagnostic tests for cancer | $2M | 26/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Cofactor Genomics's competitors? Click here to see the top ones
Cofactor Genomics's Investments and acquisitions
Cofactor Genomics has acquired Narus Biotechnologies. Cofactor Genomics has not made any investments as of now.Reports related to Cofactor Genomics
Here is the latest report on Cofactor Genomics's geography:
News related to Cofactor Genomics
Filter this listMedia has covered Cofactor Genomics for 1 event in last 1 year.
•
•
•
•
•
•
•
•
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Cofactor Genomics
Explore our recently published companies
- Wisdom Square Technologies - New Hyde Park based, 2008 founded, Unfunded company
- Fruverpack - Almoradi based, 1992 founded, Unfunded company
- AERA - Bouxwiller based, 1979 founded, Unfunded company
- Divine Hindu - Ujjain based, 2023 founded, Unfunded company
- Globaldigitalpartner.com - 2013 founded, Unfunded company
- OROK - Bourgoin Jallieu based, 2018 founded, Deadpooled company
